Literature DB >> 11583768

Introduction to health economics for physicians.

M I Meltzer1.   

Abstract

Since the 1960s, expenditure on health care in developed countries has risen faster than the general rate of inflation, thus making economic assessment of interventions an integral part of decision making in health services. This paper is the first in a series whose goal is to provide some basic principles of health economics that will allow practising physicians to understand better the economic relations between their practice of medicine, the health-care sector, and the national economy. Some of the most important principles described in this paper include opportunity costs, identifying the appropriate perspective, correctly categorising costs, and discounting costs and non-monetary benefits (eg, lives saved) over time. Economic analyses of medical interventions must also take into consideration the difference between efficacy and effectiveness. Efficacy is the maximum possible benefit, often achieved with carefully controlled trials, and effectiveness is the actual decrease in disease achieved when the intervention is applied over a large, non-homogeneous population. This introduction ends with three methods of assessing the costs and benefits of an intervention-namely, cost-benefit, cost-effectiveness, and cost-utility analyses.

Mesh:

Year:  2001        PMID: 11583768     DOI: 10.1016/S0140-6736(01)06107-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  20 in total

1.  Recommendations of the current guidelines for implantable cardioverter-defibrillator implantation in patients with hypertrophic cardiomyopathy: Debate still exists.

Authors:  Arya Aminorroaya; Ali Vasheghani-Farahani; Farzad Masoudkabir; Pegah Roayaei
Journal:  J Interv Card Electrophysiol       Date:  2020-07-25       Impact factor: 1.900

Review 2.  Cost-effectiveness of implantable cardioverter-defibrillator in today's world.

Authors:  Giuseppe Boriani; Paolo Cimaglia; Mauro Biffi; Cristian Martignani; Matteo Ziacchi; Cinzia Valzania; Igor Diemberger
Journal:  Indian Heart J       Date:  2013-12-31

3.  Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.

Authors:  Agnes L F Chan; Henry W C Leung; Shiao-Feng Huang
Journal:  Clin Drug Investig       Date:  2011-10-01       Impact factor: 2.859

Review 4.  Value-based care in the management of spinal disorders: a systematic review of cost-utility analysis.

Authors:  Santoshi S Indrakanti; Michael H Weber; Steven K Takemoto; Serena S Hu; David Polly; Sigurd H Berven
Journal:  Clin Orthop Relat Res       Date:  2012-04       Impact factor: 4.176

5.  Syndromic management of common illnesses in hospitalized children and neonates: a cost identification study.

Authors:  Subhashchandra Daga; Bela Verma; Satish Shahane; Sunil Janged; M Mani Vachagan
Journal:  Indian J Pediatr       Date:  2010-09-16       Impact factor: 1.967

6.  Implications and cost of pancreatic leak following distal pancreatic resection.

Authors:  J Rubén Rodríguez; Santos Soto Germes; Pari V Pandharipande; G Scott Gazelle; Sarah P Thayer; Andrew L Warshaw; Carlos Fernández-del Castillo
Journal:  Arch Surg       Date:  2006-04

7.  The costs for persons sick-listed more than one month because of low back or neck problems. A two-year prospective study of Swedish patients.

Authors:  Elisabeth K Hansson; Tommy H Hansson
Journal:  Eur Spine J       Date:  2004-05-19       Impact factor: 3.134

8.  Study protocol of cost-effectiveness and cost-utility of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial.

Authors:  Anna Berenguera; Enriqueta Pujol-Ribera; Teresa Rodriguez-Blanco; Concepció Violan; Marc Casajuana; Nelleke de Kort; Marta Trapero-Bertran
Journal:  BMC Musculoskelet Disord       Date:  2011-08-22       Impact factor: 2.362

9.  Social contact networks and disease eradicability under voluntary vaccination.

Authors:  Ana Perisic; Chris T Bauch
Journal:  PLoS Comput Biol       Date:  2009-02-06       Impact factor: 4.475

10.  Executive summary: aligning stakeholder incentives in orthopaedics.

Authors:  Natalia A Wilson; Anil Ranawat; Ryan Nunley; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2009-06-06       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.